9-35740562-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_020944.3(GBA2):c.1093G>A(p.Asp365Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000128 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020944.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 46Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive cerebellar ataxia with late-onset spasticityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GBA2 | ENST00000378103.7 | c.1093G>A | p.Asp365Asn | missense_variant | Exon 6 of 17 | 1 | NM_020944.3 | ENSP00000367343.3 | ||
| GBA2 | ENST00000378094.4 | c.1093G>A | p.Asp365Asn | missense_variant | Exon 6 of 17 | 1 | ENSP00000367334.4 | |||
| GBA2 | ENST00000467252.5 | n.665G>A | non_coding_transcript_exon_variant | Exon 3 of 13 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152120Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251322 AF XY: 0.0000663 show subpopulations
GnomAD4 exome AF: 0.000127 AC: 186AN: 1461714Hom.: 0 Cov.: 31 AF XY: 0.000122 AC XY: 89AN XY: 727172 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000138 AC: 21AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74436 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GBA2 protein function. ClinVar contains an entry for this variant (Variation ID: 580695). This variant has not been reported in the literature in individuals affected with GBA2-related conditions. This variant is present in population databases (rs201219745, gnomAD 0.01%). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 365 of the GBA2 protein (p.Asp365Asn). -
Inborn genetic diseases Uncertain:1
The c.1093G>A (p.D365N) alteration is located in exon 6 (coding exon 6) of the GBA2 gene. This alteration results from a G to A substitution at nucleotide position 1093, causing the aspartic acid (D) at amino acid position 365 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at